Beda Statler

Title: **The Innovations of Beda Statler: Pioneer in Antigen Binding Structures**

Introduction

Beda Statler, an accomplished inventor based in Bern, Switzerland, has made significant contributions in the field of biochemistry. With a focus on polypeptides and their applications in medicine, he aims to advance understanding and treatment options for conditions related to Rhesus D antigens.

Latest Patents

Beda Statler holds a noteworthy patent titled "Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them, and the process for their preparation and use." This innovative patent encompasses the development of polypeptides that act as Fab fragments, which can be utilized directly as active ingredients in pharmaceutical and diagnostic compositions. Additionally, the DNA sequences associated with these polypeptides can facilitate the creation of complete recombinant Anti-Rhesus D antibodies, proving useful in various therapeutic and diagnostic contexts.

Career Highlights

Beda Statler is currently affiliated with ZLB Bioplasma AG, where he continues to research and develop cutting-edge solutions within the biopharmaceutical industry. His work exemplifies the bridge between scientific innovation and practical application, particularly in improving medical diagnostics and treatments.

Collaborations

Beda Statler collaborates with esteemed colleagues, including Andreas Morell and Martin Imboden. These partnerships enhance the research capabilities and foster an environment of creative scientific exchange, culminating in advancements that benefit the larger medical community.

Conclusion

Through his pioneering work and innovative spirit, Beda Statler exemplifies the essential role of inventors in shaping the future of medicine. His patent on polypeptides related to Rhesus D antigens has the potential to significantly impact pharmaceutical and diagnostic practices, solidifying his legacy within the scientific community.